↓ Skip to main content

Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics

Overview of attention for article published in Molecular Therapy - Methods & Clinical Development, June 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics
Published in
Molecular Therapy - Methods & Clinical Development, June 2021
DOI 10.1016/j.omtm.2021.06.007
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Professor > Associate Professor 2 11%
Student > Master 2 11%
Unspecified 1 5%
Student > Ph. D. Student 1 5%
Lecturer > Senior Lecturer 1 5%
Other 0 0%
Unknown 12 63%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 2 11%
Unspecified 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Economics, Econometrics and Finance 1 5%
Medicine and Dentistry 1 5%
Other 1 5%
Unknown 12 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2021.
All research outputs
#19,160,157
of 27,790,740 outputs
Outputs from Molecular Therapy - Methods & Clinical Development
#1,060
of 1,316 outputs
Outputs of similar age
#286,119
of 462,891 outputs
Outputs of similar age from Molecular Therapy - Methods & Clinical Development
#26
of 36 outputs
Altmetric has tracked 27,790,740 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,316 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,891 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.